Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    10561020 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Phase I Study of MEDI-507 to Treat Lymphoproliferative Disease
Condition: Lymphoproliferative Disorders
Intervention: Drug: MEDI-507
2 Completed Phase I Study of HeFi-1 to Treat Cancers With CD30 Protein
Condition: Neoplasms
Intervention: Drug: HeFi-1 Monoclonal Antibody

Indicates status has not been verified in more than two years